Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis.

We suggest that urologic malignancies in renal transplant recipients can be investigated for transplant origin. In addition to conventional therapy the allograft immune response against these tumours can be valuable to treat donor-derived cancers.